AlphaOne Investment Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

AlphaOne Investment Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,000	Closed	-$311K	–	104
2014 Q2	$311K	Sell	5,000 -24,081	-83%	-$1.45M	0.08%	114
2014 Q1	$1.98M	Buy	29,081 +15,642	+116%	+$1.15M	0.46%	85
2013 Q4	$944K	Buy	13,439 +7,400	+123%	+$503K	0.21%	106
2013 Q3	$436K	Sell	6,039 -2,200	-27%	-$146K	0.11%	146
2013 Q2	$460K	Buy	+8,239	New	+$513K	0.12%	147

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AlphaOne Investment Services's BMRN Position: Q3 2014 in Review

AlphaOne Investment Services sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2014, closing a stake of 5,000 shares — an estimated $311K sold.

AlphaOne Investment Services first reported a position in BMRN in Q2 2013 and held it in 5 quarters. The position peaked at $1.98M in Q1 2014. 316 funds tracked by Wall St. Rank hold BMRN as of Q3 2014.

AlphaOne Investment Services reported no remaining BioMarin Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
AlphaOne Investment Services sold 5,000 BioMarin Pharmaceuticals shares in Q3 2014, an estimated $311K.
AlphaOne Investment Services first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 5 quarters.
AlphaOne Investment Services's BioMarin Pharmaceuticals position peaked at $1.98M in Q1 2014.
316 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2014.

Based on AlphaOne Investment Services's 13F filing for Q3 2014, filed 13 Nov 2014.